Type Size

    Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus.

    In this manuscript the authors demonstrate that circulating sclerostin levels are increased in type 2 diabetes mellitus and this correlation was independent of gender and age. Serum sclerostin also correlated with the duration of disease, glycated hemoglobin, bone turnover markers, and BMD.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details